EKTA-B.ST
EKTA-B.ST
SE0000163628
Elekta AB ser. B
Loading chart...

Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Elekta Care, a personalized services for radiotherapy suites. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Elekta Geneva, an applicator for cervical cancer patients; and Elekta Xoft Axxent electronic brachytherapy systems. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning; Elekta Care Community, a self-help center; and Elekta Partner Community, an online self-service portal. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Related stocks

NOLA-B.ST
NOLA-B.ST • Sweden
Nolato AB ser. B
57.1 SEK
1.54B USD 1Y -6.9%
SECT-B.ST
SECT-B.ST • Sweden
SECTRA AB ser B
310.2 SEK
5.98B USD 1Y -1.9%
NVCR
NVCR • Switzerland
NovoCure Limited
14.58 USD
1.7B USD 1Y -0.9%
MOVE.SW
MOVE.SW • Switzerland
MEDACTA GROUP N
114.2 CHF
2.74B USD 1Y -25.8%
GETI-B.ST
GETI-B.ST • Sweden
Getinge AB ser. B
253.2 SEK
6.9B USD 1Y +18%
ELN.MI
ELN.MI • Italy
EL.EN.
16.05 EUR
1.44B USD 1Y +34.9%
VITR.ST
VITR.ST • Sweden
Vitrolife AB
95.6 SEK
1.3B USD 1Y -33.5%
DRW8.DE
DRW8.DE • Germany
DRAEGERWERK ST.A.O.N.
90 EUR
1.89B USD 1Y +69%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
36.7% p.a.
Max Drawdown (5Y)
-65.1%
Sharpe Ratio (5Y)
-0.39
Beta Factor
0.96
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.6% in the extended horizon.
ende